MYCIO Wealth Partners’s Antares Pharma, Inc. ATRS Stock Holding History

MYCIO Wealth Partners’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,353,970	Closed	-$6.36M	–	448
2019 Q4	$6.36M	Sell	1,353,970 -270,000	-17%	-$1.1M	0.41%	33
2019 Q3	$5.43M	Sell	1,623,970 -2,530	-0.2%	-$8.33K	0.4%	35
2019 Q2	$5.35M	Hold	1,626,500	–	–	0.42%	34
2019 Q1	$4.93M	Sell	1,626,500 -270,000	-14%	-$875K	0.41%	36
2018 Q4	$5.16M	Sell	1,896,500 -262,000	-12%	-$863K	0.48%	33
2018 Q3	$7.25M	Sell	2,158,500 -275,000	-11%	-$849K	0.7%	22
2018 Q2	$6.28M	Buy	+2,433,500	New	+$6.06M	0.65%	24

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MYCIO Wealth Partners's ATRS Position: Q1 2020 in Review

MYCIO Wealth Partners sold out of Antares Pharma, Inc. (ATRS) in Q1 2020, closing a stake of 1,353,970 shares — an estimated $6.36M sold.

MYCIO Wealth Partners first reported a position in ATRS in Q2 2018 and held it in 7 quarters. The position peaked at $7.25M in Q3 2018. 154 funds tracked by Wall St. Rank hold ATRS as of Q1 2020.

MYCIO Wealth Partners reported no remaining Antares Pharma, Inc. position as of Q1 2020 after selling out during the quarter.
MYCIO Wealth Partners sold 1,353,970 Antares Pharma, Inc. shares in Q1 2020, an estimated $6.36M.
MYCIO Wealth Partners first reported a position in Antares Pharma, Inc. in Q2 2018 and held it in 7 quarters.
MYCIO Wealth Partners's Antares Pharma, Inc. position peaked at $7.25M in Q3 2018.
154 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2020.

Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.